When Ceribell went public in October, the window for medtech initial public offerings was open just a crack — if not shut completely. Ceribell, which develops technology to diagnose patients with neurological disorders, led a rush of public offerings activity in just a few months, breaking a three-year drought in IPOs. The new public offerings prompted questions about whether the medical device industry could have another IPO moment after a 2021 spike. There were 51 IPOs in 2021, up from 24 the prior year, according to data from PitchBook, which includes private equity and venture capital offerings. “But since then, it’s been pretty tough,” Aaron DeGagne, a senior healthcare analyst with PitchBook, said.
Read the full article: The Medtech IPO Window Is Finally Open. Or Is It? //
Source: https://www.medtechdive.com/news/medtech-ipo-window-ceribell-beta-bionics/749050/